Related Experiment Video
Updated: May 12, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
From Psychiatric Care to Dermatologic Dilemmas: A Case Report of Risperidone-Induced Bullous Pemphigoid
Mohd Rashid Alam1, Samant Singh1, Astha Agarwal1
1Psychiatry, All India Institute of Medical Sciences, Gorakhpur, Gorakhpur, IND.
Abstract:
The patient, a 64-year-old male with a history of delusional disorder, first experienced symptoms of suspicion toward his spouse at age 34. He was treated with psychotropic drugs for two years, leading to complete symptom remission and discontinuation of medication. After years of stability, delusions resurfaced two years ago. Amisulpride was ineffective, and risperidone was started but led to itching and plaques on his thighs, which evolved into fluid-filled and hemorrhagic lesions. Diagnosed with bullous pemphigoid (BP) via skin biopsy, he received corticosteroids, dapsone, and antibiotics. Risperidone was discontinued, but delusions reappeared, prompting its reintroduction. New bullous lesions emerged, suggesting risperidone's role in triggering them. Risperidone was replaced with aripiprazole, and melatonin improved sleep. The patient responded well, with both delusional symptoms and skin condition well-managed. This case highlights the need to consider drug-induced BP in elderly patients on antipsychotic medications.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Bulimia Nervosa
Drug Therapy
Antianxiety Medications
Borderline Personality Disorder
Genetic and Environmental Contributions
Borderline Personality...

